Molecular triggers of neuroinflammation in mouse models of demyelinating diseases
- PMID: 23959664
- DOI: 10.1515/hsz-2013-0219
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases
Abstract
Myelinating cells wrap axons with multi-layered myelin sheaths for rapid impulse propagation. Dysfunctions of oligodendrocytes or Schwann cells are often associated with neuroinflammation, as observed in animal models of leukodystrophies and peripheral neuropathies, respectively. The neuroinflammatory response modulates the pathological changes, including demyelination and axonal injury, but also remyelination and repair. Here we discuss different immune mechanisms as well as factors released or exposed by myelinating glia in disease conditions. The spectrum of inflammatory mediators varies with different myelin disorders and has a major impact on the beneficial or detrimental role of immune cells in keeping nervous system integrity.
Similar articles
-
Demyelination in peroxisomal diseases.J Neurol Sci. 2005 Feb 15;228(2):206-7. doi: 10.1016/j.jns.2004.10.012. Epub 2004 Dec 2. J Neurol Sci. 2005. PMID: 15694208 Review. No abstract available.
-
Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease.Stem Cells. 2016 Apr;34(4):984-96. doi: 10.1002/stem.2263. Epub 2015 Dec 31. Stem Cells. 2016. PMID: 26676415
-
Oligodendroglial impact on axonal function and survival - a hypothesis.Curr Opin Neurol. 2008 Jun;21(3):235-41. doi: 10.1097/WCO.0b013e328300c71f. Curr Opin Neurol. 2008. PMID: 18451704 Review.
-
Myelination of the nervous system: mechanisms and functions.Annu Rev Cell Dev Biol. 2014;30:503-33. doi: 10.1146/annurev-cellbio-100913-013101. Annu Rev Cell Dev Biol. 2014. PMID: 25288117 Review.
-
Remyelinating strategies in multiple sclerosis.Expert Rev Neurother. 2014 Nov;14(11):1315-34. doi: 10.1586/14737175.2014.969241. Expert Rev Neurother. 2014. PMID: 25331418 Review.
Cited by
-
Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives.Mol Genet Metab Rep. 2020 Dec 11;25:100688. doi: 10.1016/j.ymgmr.2020.100688. eCollection 2020 Dec. Mol Genet Metab Rep. 2020. PMID: 33335837 Free PMC article.
-
Microbiota gut-brain axis: implications for pediatric-onset leukodystrophies.Front Nutr. 2024 Jul 12;11:1417981. doi: 10.3389/fnut.2024.1417981. eCollection 2024. Front Nutr. 2024. PMID: 39070252 Free PMC article. Review.
-
Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective.Orphanet J Rare Dis. 2019 Nov 4;14(1):240. doi: 10.1186/s13023-019-1220-4. Orphanet J Rare Dis. 2019. PMID: 31684987 Free PMC article. Review.
-
Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation.Brain Pathol. 2018 Nov;28(6):902-919. doi: 10.1111/bpa.12595. Epub 2018 Apr 10. Brain Pathol. 2018. PMID: 29476661 Free PMC article.
-
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis.Mol Ther. 2017 Aug 2;25(8):1889-1899. doi: 10.1016/j.ymthe.2017.04.021. Epub 2017 May 13. Mol Ther. 2017. PMID: 28506594 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical